DENVER, CO / ACCESSWIRE / August 6, 2015 / AmeriCann, Inc. (ACAN), a company that designs, develops and owns advanced medical cannabis facilities, reports positive results from its partnership with a Colorado cannabis producer.

Over one year ago, AmeriCann formed a partnership with 4900 Jackson, LLC, an experienced and licensed Colorado cannabis producer. AmeriCann provided design, development and operational support combined with $1,000,000 in capital to efficiently renovate a 15,000 square foot industrial building in Denver, Colorado. The capital was deployed in the form of a loan and the terms were structured to allow for consulting and interest only payments during the early stages of the operation.

Together the partners converted the building into a highly efficient, state-of-the-art cannabis cultivation and processing facility operated by 4900 Jackson, LLC.

“Over the last year our partnership with AmeriCann has allowed us to expand our production by over 4 times,” stated John Ray, Managing Partner of 4900 Jackson, LLC. Mr. Ray went on to say that “AmeriCann’s expertise was instrumental in the success of our business. Since beginning our partnership AmeriCann has continued to grow and strengthen their team and we expect them to be very successful in new markets.”

Tim Keogh, Chief Executive Officer of AmeriCann, stated, “This initial deal, the collaborative efforts and its positive results, demonstrates AmeriCann’s ability to successfully participate in the complex, rapidly growing cannabis industry. This has been a very good mutual partnership for AmeriCann and our partner over the past year. While we are very pleased with this partnership, our strategy is focused on retaining a recurring aspect of future deals and partnerships.”

In the year since the partnership started and AmeriCann loaned 4900 Jackson, LLC $1,000,000, AmeriCann has been repaid over $630,000 of its investment and now receives $37,600 cash flow per month. The future monthly payments will bring in an expected $827,200 more over the next 22 months to AmeriCann.

AmeriCann is becoming a national leader in the design and development of high tech, sustainable cannabis cultivation and processing facilities. The Company currently has over 1,000,000 square feet of facilities in planning, design and development stages with partners in multiple states.

AmeriCann has designed the “Preferred Partner Program” whereby it partners with entrepreneurs in newly regulated markets to provide expertise and infrastructure to help build long-term sustainable businesses that meet the needs of medical cannabis patients throughout the country.

About AmeriCann

AmeriCann designs, develops and owns advanced medical cannabis facilities to produce the best possible medical cannabis in the most efficient manner utilizing advanced, sustainable practices. The Company has over 1,000,000 square feet of facilities in development. AmeriCann does not cultivate, process or distribute cannabis, but partners with local business to serve marijuana patients in their communities. More information about the Company is available at:https://www.acaninfo.com

Forward-Looking Statements

Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise.

Contact Information

Investors:

Hayden IR
hart@haydenir.com
917-658-7878

Media:

media@ACANinfo.com
303-862-9000

SOURCE: AmeriCann, Inc.